Intracellular thiopurine nucleotides and azathioprine myelotoxicity in organ transplant patients

British Journal of Clinical Pharmacology

Volumn 43, Issue 1, 1997, Pages 116-118

  Boulieu, Roselyne ^a,b   Lenoir, Alain ^a,b   Bertocchi, Michèle ^b   Mornex, Jean François ^b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Azathioprine; Myelotoxicity; Organ transplantation; Thiopurine nucleotides

Indexed keywords

6 THIOXANTHINE; AZATHIOPRINE; MERCAPTOPURINE; TIOGUANINE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; ERYTHROCYTE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LYMPHOCYTE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0031029459     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1997.tb00148.x     Document Type: Article

References (12)

1. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992; 43: 329-339.
2. Chocair PR, Duley JA, Simmonds HA, Cameron JS. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 1992; 53: 1051-1056.
3. Van Scoïk KG, Johnson CA, Porter WR. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metab Rev 1985; 16: 157.
4. Lennard L, Brown CB, Fox M, Maddocks JL. Azathioprine metabolism in kidney transplant recipients. Br J Clin Pharmacol 1984; 18: 693-700.
5. Chan GLC, Erdmann GR, Gruber SA, Matas AJ, Canafax DM. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 1990; 30: 358-363.
6. Anstey A, Lennard L, Mayou SC, Kirby JD. Pancytopenia related to azathioprine - An enzyme deficiency caused by a common genetic polymorphism: a review. J Roy Soc Med 1992; 85: 752-756.
7. McLeod HL, Miller DR, Evans WE. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341: 1151.
8. Soria-Royer C, Legendre C, Mircheva J, Premel S, Beaune P, Kreis H. Thiopurine-methyl-transferase activity to assess azathioprine myelotoxicity in renal transplant recipients. Lancet 1993; 341: 1593.
9. Boulieu R, Lenoir A, Bory C. High performance liquid chromatographic determination of thiopurine metabolites of azathioprine in biological fluids. J Chromatogr 1993; 615: 352-356.
10. Lennard L, Murphy MF, Maddocks JL. Severe megaloblastic anemia associated with abnormal azathioprine metabolism. Br J Clin Pharmacol 1984; 17: 171-172.
11. Bergan S, Rugstad HE, Bentdal O, Stokke O. Monitoring of azathioprine treatment by determination of 6-thioguanine nucleotide concentration in erythrocytes. Transplantation 1994; 58: 803-808.
12. Schutz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M. Azathioprine related to elevated 6-thioguanine nucleotides in heart transplantation. Transplant Proc 1995; 27: 1298-1300.